Home > Insider Trading > Filing (0001127602-20-001677)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
859737	Hologic Inc	HOLX	X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844)	042902449

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1630909	M. John Griffin	250 Campus Drive Marlborough MA 01752	General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-01-13	8,532	$35.38	103,839	No	4	M	Direct
Common Stock	Disposition	2020-01-13	8,532	$52.97	95,307	No	4	S	Direct
Common Stock	Acquisiton	2020-01-13	11,092	$32.38	106,399	No	4	M	Direct
Common Stock	Disposition	2020-01-13	11,092	$52.78	95,307	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-qualified Stock Option (Right to Buy)	Disposition	2020-01-13	8,532	$0.00	8,532	$32.38
Common Stock	Non-qualified Stock Option (Right to Buy)	Disposition	2020-01-13	11,092	$0.00	11,092	$32.38

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2,133		2025-03-01	No	4	M	Direct
2,773		2025-03-01	No	4	M	Direct

Footnotes

Transaction pursuant to an existing Rule 10b5-1 trading plan.
Includes 43,871 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan.
The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $52.60 to $53.56 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.
The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $52.59 to $53.51 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.
This option to purchase common stock becomes exercisable in equal installments on each of the first five anniversaries of the grant date, March 1, 2015.